{
  "ticker": "NVDA",
  "report": {
    "date": "2026-02-19",
    "institution": "ISS EVA",
    "institution_en": "ISS EVA (PRVit)",
    "analyst": "Gavin Thomson",
    "rating": "增持",
    "target_price": 187.9,
    "sentiment_score": 0.55,
    "views": [
      {
        "topic": "PRVit 综合评级：OVERWEIGHT (71)",
        "stance": "bullish",
        "confidence": "high",
        "summary": "PRVit 综合评分 71（vs Industry），评级 OVERWEIGHT。盈利能力 P=100（满分），风险 R=56（中等偏低），估值 V=98（极高）。Quality Score (P-R)=84，属于高质量但高估值组合。",
        "data_points": [
          "PRVit Score vs Industry: 71",
          "P Score: 100",
          "R Score: 56",
          "V Score: 98",
          "Quality Score (P-R): 84",
          "PAS: 4"
        ],
        "predictions": []
      },
      {
        "topic": "盈利能力：行业顶级且趋势强劲",
        "stance": "bullish",
        "confidence": "high",
        "summary": "EVA Margin 48.5%（行业98百分位），EVA Spread 155.5%（行业100百分位）。三年 EVA Momentum 94.2%（行业100百分位）。EBITDAR Margin 71.7%，NOPAT $96.5B，ROC 165.3% vs COC 9.8%，经济利润极为丰厚。",
        "data_points": [
          "EVA Margin: 48.5% (98th %ile)",
          "EVA Spread: 155.5% (100th %ile)",
          "ROC: 165.3%",
          "COC: 9.8%",
          "NOPAT: $96.5B",
          "EBITDAR Margin: 71.7%",
          "Sales: $187.1B",
          "Sales Growth: 65.2% YoY"
        ],
        "predictions": []
      },
      {
        "topic": "风险画像：波动性高但现金流极强",
        "stance": "neutral",
        "confidence": "high",
        "summary": "R Score 56（风险中等）。股价波动率 41.9%（行业仅6百分位，即波动极高）；但 FCF Rate 106.3%、OCG Return 495.7% 均为行业最优（0百分位=最低风险），债务极低（Debt/Capital 7.8%，Debt/EBITDAR 0.1x）。波动性是主要风险来源，而非基本面脆弱性。",
        "data_points": [
          "Stock Price Volatility: 41.9% (6th %ile)",
          "EVA Margin Variability: 16.0% (68th %ile)",
          "FCF Rate: 106.3%",
          "OCG Return: 495.7%",
          "Debt/Capital: 7.8%",
          "Debt/EBITDAR: 0.1x",
          "FCF: $62.0B"
        ],
        "predictions": []
      },
      {
        "topic": "估值：极度拉伸，未来增长依赖度 77%",
        "stance": "bearish",
        "confidence": "high",
        "summary": "V Score 98（极高估值）。MVA Margin 2,380%，MVA Spread 5,620%，NOPAT Multiple 47.0x，EBITDAR Multiple 33.8x。Future Growth Reliance 77.2%——即当前市值中 77% 依赖于尚未实现的未来 EVA 增长。市场隐含 EVA Margin 为 65.5%，高于当前 48.5%，意味着市场预期盈利能力还需大幅提升。",
        "data_points": [
          "MVA Margin: 2,380%",
          "MVA Spread: 5,620%",
          "EBITDAR Multiple: 33.8x",
          "NOPAT Multiple: 47.0x",
          "FGR: 77.2%",
          "Market-Implied EVA Margin: 65.5% vs Current 48.5%",
          "Market Cap: $4,566.9B",
          "FVA: $3,498B"
        ],
        "predictions": []
      },
      {
        "topic": "运营效率：多项指标行业领先",
        "stance": "bullish",
        "confidence": "high",
        "summary": "Strong Points 显示：销售增长极快、毛利率行业上四分位且加速、SG&A 轻且收缩、应收账款低于均值且收缩、库存精益且收紧、PP&E 利用率极高且改善中。Red Flags 仅两项：R&D 投入可能过少（占比持续下降至 5.9%）、战略展望下滑。",
        "data_points": [
          "COGS Adjusted: 26.0% of Sales",
          "SG&A Adjusted: 2.3% of Sales",
          "R&D Intangibles Charge: 5.9% of Sales (declining)",
          "Cap Chrg Net PP&E: 1.9% of Sales",
          "Working Capital Charge: 2.3% of Sales"
        ],
        "predictions": []
      },
      {
        "topic": "历史评级轨迹与当前定位",
        "stance": "neutral",
        "confidence": "medium",
        "summary": "2025年5月从 HOLD(53) 升级至 OVERWEIGHT(66)，当前进一步升至 71。历史上 PRVit 最高曾达 BUY(88)（2012年）。当前评级处于偏高区间但未达最高档，反映盈利极强但估值压制了综合评分。行业中位数仅 16，NVDA 远超同业。",
        "data_points": [
          "Current: OVERWEIGHT 71 (Feb 2026)",
          "Previous: HOLD 53 (Apr 2025)",
          "Industry Median: 16",
          "PRVit vs Market: 34"
        ],
        "predictions": []
      }
    ],
    "key_metrics": {
      "revenue_estimate": "187142",
      "eps_estimate": null,
      "growth_rate": "65.2",
      "margin_estimate": "48.5",
      "other": {
        "EVA": "$90.8B",
        "NOPAT": "$96.5B",
        "Capital": "$79.3B",
        "ROC": "165.3%",
        "COC": "9.8%",
        "EVA_Spread": "155.5%",
        "EBITDAR_Margin": "71.7%",
        "FCF": "$62.0B",
        "Market_Cap": "$4,566.9B",
        "FGR": "77.2%",
        "NOPAT_Multiple": "47.0x",
        "EBITDAR_Multiple": "33.8x",
        "Debt_to_Capital": "7.8%",
        "PRVit_Score_vs_Industry": "71",
        "P_Score": "100",
        "R_Score": "56",
        "V_Score": "98"
      }
    },
    "key_assumptions": [
      "PRVit 为纯量化模型，基于 Russell 3000 全样本统计排名，不含主观判断",
      "EVA 框架将 R&D 资本化处理，与 GAAP 口径不同，影响利润率与资本回报率计算",
      "所有数据基于 Trailing Four Quarters (TFQ) 截至 2025年10月31日，不含最新季度",
      "风险评分中波动率权重较高，导致高波动但基本面强劲的公司 R 分偏低",
      "估值评分反映的是相对排名而非绝对高估/低估判断"
    ],
    "risk_factors": [
      "Future Growth Reliance 77.2%：市值中超过3/4依赖未实现的未来增长，若增长不及预期，估值回撤空间巨大",
      "市场隐含 EVA Margin 65.5% 远高于当前 48.5%，需要盈利能力再提升约 35% 才能匹配当前股价",
      "股价波动率 41.9%（行业仅6百分位），短期回撤风险显著高于同业",
      "R&D 占比持续下降（从 24.9% 降至 5.9%），被标记为 Red Flag——长期可能削弱技术护城河",
      "EVA Momentum 从 87.2% 降至 31.5%（YoY），盈利增速边际放缓",
      "Strategic Outlook 被标记为 slumping，Market Valuation contracting——估值收缩趋势已现"
    ],
    "blind_spots": [
      "PRVit 纯量化框架不考虑 AI/数据中心需求的定性前景与竞争格局变化",
      "不含最新一季财报数据（TFQ 截至 Oct 2025），可能遗漏近期业绩拐点信号",
      "未涵盖地缘政治风险（出口管制、中国市场限制）对收入结构的潜在冲击",
      "R&D 占比下降可能是规模效应而非真正投入不足，但模型无法区分",
      "不含期权隐含波动率、机构持仓变化等市场微观结构信息"
    ],
    "catalysts": [
      {
        "event": "FY2026 Q4 财报发布（预计2026年2月下旬）——验证 EVA Momentum 是否企稳",
        "expected_date": "2026-02-26",
        "importance": "high",
        "related_views": [
          "盈利能力：行业顶级且趋势强劲",
          "估值：极度拉伸，未来增长依赖度 77%"
        ]
      },
      {
        "event": "GTC 2026 开发者大会——新产品路线图可能改变 R&D 投入不足的叙事",
        "expected_date": "2026-03-17",
        "importance": "high",
        "related_views": [
          "运营效率：多项指标行业领先"
        ]
      },
      {
        "event": "PRVit 下一次评级变动——若 P 维持满分但 V 继续攀升，可能触发降级",
        "expected_date": "TBD",
        "importance": "medium",
        "related_views": [
          "PRVit 综合评级：OVERWEIGHT (71)"
        ]
      }
    ],
    "chart_insights": [
      {
        "chart_name": "EVA Margin & Momentum 趋势图",
        "chart_type": "line",
        "source_file": "ISS-EVA-NVDA-20260219.pdf Page 1",
        "description": "EVA Margin（红线）过去11个季度整体上行，当前 48.5%；EVA Momentum（蓝线）过去1.5年持续下降，显示增速边际放缓。市场隐含 EVA Margin 65.5%（红十字线）远高于当前水平。",
        "key_observations": [
          "EVA Margin 正向但增速放缓",
          "市场预期 vs 实际存在 17pp 缺口",
          "Momentum 下行趋势需关注是否企稳"
        ],
        "data_not_in_text": [
          "市场隐含 EVA Margin 65.5% 的具体计算路径"
        ],
        "investment_implication": "盈利绝对水平极强，但增速放缓+市场预期过高=估值压力来源"
      },
      {
        "chart_name": "Capital / CVA / FVA 分解图",
        "chart_type": "bar",
        "source_file": "ISS-EVA-NVDA-20260219.pdf Page 2",
        "description": "Capital（蓝柱）$79.3B，CVA（红柱）$956B，FVA（灰柱）$3,498B。市值虚线约 $4,533B。FVA 占比极高，说明绝大部分市值建立在未来增长预期之上。",
        "key_observations": [
          "FVA 占 MVA 的 78.5%",
          "CVA 已从 2024TFQ3 的 $610B 升至 $956B",
          "Capital 从 $45B 升至 $79B，资本投入加速"
        ],
        "data_not_in_text": [],
        "investment_implication": "若未来 EVA 增长不及预期，FVA 收缩将直接压缩市值"
      },
      {
        "chart_name": "EVA Income Statement 10年趋势",
        "chart_type": "table",
        "source_file": "ISS-EVA-NVDA-20260219.pdf Page 2",
        "description": "10年 EVA 收入表显示：Sales 从 $6.1B 增至 $187.1B（30x），EVA Margin 从 12.8% 升至 48.5%，但 EVA Momentum 从 87.2% 降至 31.5%。COGS 占比从 38.2% 降至 26.0%，SG&A 从 10.2% 降至 2.3%，运营杠杆极强。",
        "key_observations": [
          "Productivity Gains 从 +13.0% 降至 -0.2%，效率提升接近极限",
          "Profitable Growth 仍贡献 31.6%，主要靠规模驱动",
          "税率稳定在 ~24%"
        ],
        "data_not_in_text": [],
        "investment_implication": "利润率扩张空间收窄，未来增长更依赖收入规模而非效率提升"
      }
    ],
    "cross_comparison": {
      "vs_previous_reports": [],
      "consensus_position": "ISS EVA PRVit 给出 OVERWEIGHT(71)，与其他机构普遍看多一致，但通过量化框架明确指出估值风险（V=98）和增速放缓（Momentum 下行）。相比传统卖方研报，PRVit 更侧重经济利润质量而非收入增长叙事，提供了差异化的风险视角。"
    }
  }
}